Two Sigma Securities’s Humacyte Inc Warrant HUMAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.85K Sell
42,124
-3,218
-7% -$368 ﹤0.01% 1530
2025
Q4
$4.25K Buy
+45,342
New +$8.67K ﹤0.01% 1348

Other funds holding HUMAW

Two Sigma Securities's HUMAW Position: Q1 2026 in Review

Two Sigma Securities reduced its Humacyte Inc Warrant (HUMAW) stake by 7.1% in Q1 2026, selling an estimated $368 and leaving 42,124 shares worth $3.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1530.

Two Sigma Securities first reported a position in HUMAW in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.25K in Q4 2025. 7 funds tracked by Wall St. Rank hold HUMAW as of Q1 2026.

  • Two Sigma Securities held 42,124 shares of Humacyte Inc Warrant worth $3.85K as of Q1 2026.
  • Two Sigma Securities sold 3,218 Humacyte Inc Warrant shares in Q1 2026, an estimated $368.
  • Humacyte Inc Warrant made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1530 holding.
  • Two Sigma Securities first reported a position in Humacyte Inc Warrant in Q4 2025 and has held it in 2 quarters since.
  • Two Sigma Securities's Humacyte Inc Warrant position peaked at $4.25K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.